The antibiotic road to poverty

Think you pay too much for prescription drugs? An interesting study released today in PLoS Medicine, an online journal, offers a bit of global perspective: For tens of millions of people around the world, buying a basic drug like the antibiotic amoxicillin is a road straight to poverty.  The authors of the report took the ...

By , International Crisis Group’s senior analyst for Colombia.
ANNA ZIEMINSKI/AFP/Getty Images
ANNA ZIEMINSKI/AFP/Getty Images
ANNA ZIEMINSKI/AFP/Getty Images

Think you pay too much for prescription drugs? An interesting study released today in PLoS Medicine, an online journal, offers a bit of global perspective: For tens of millions of people around the world, buying a basic drug like the antibiotic amoxicillin is a road straight to poverty. 

Think you pay too much for prescription drugs? An interesting study released today in PLoS Medicine, an online journal, offers a bit of global perspective: For tens of millions of people around the world, buying a basic drug like the antibiotic amoxicillin is a road straight to poverty. 

The authors of the report took the cost of four basic drugs used to treat fairly ordinary conditions — diabetes, high blood pressure, asthma, and bacterial infection. Using pricing information from 16 lower- and middle-income countries, they calculated how poverty rates would rise after patients purchased the drugs. The results, while not terribly surprising, do provide a blockbuster portrayal of what we’ve long known anecdotally. Buying brand name amoxicillin, for example, would push an additional 34 percent of Uganda’s population into poverty levels of less than $1.25 a day. Even middle-income Indonesia would see an additional 39 percent of its population become poor from purchasing the drugs.

What’s to be done? One answer has been the creation of consortiums to donate and subsidize the purchase of drugs, but that system isn’t without drawbacks either. Another forthcoming study, one of whose authors is FP contributor Roger Bate, finds that corruption in the donated drug industry sees a solid percentage (6.5 percent in the study) of the anti-malarials sold off onto the market, rather than going to the government clinics where they were sent. 

Of course in many ways, these studies are two sides of the same coin. Medicines are too expensive for their consumers in many a country — and hence, the profit from selling them is (in relative terms) enough to entice people to put their medicine up on the black market. Want one more externality? Fake drugs. Patients in desperate need of a pill are susceptible to the temptation of a cheaper version — even if it’s not guaranteed to be real.

Elizabeth Dickinson is International Crisis Group’s senior analyst for Colombia.

More from Foreign Policy

An illustration shows the Statue of Liberty holding a torch with other hands alongside hers as she lifts the flame, also resembling laurel, into place on the edge of the United Nations laurel logo.
An illustration shows the Statue of Liberty holding a torch with other hands alongside hers as she lifts the flame, also resembling laurel, into place on the edge of the United Nations laurel logo.

A New Multilateralism

How the United States can rejuvenate the global institutions it created.

A view from the cockpit shows backlit control panels and two pilots inside a KC-130J aerial refueler en route from Williamtown to Darwin as the sun sets on the horizon.
A view from the cockpit shows backlit control panels and two pilots inside a KC-130J aerial refueler en route from Williamtown to Darwin as the sun sets on the horizon.

America Prepares for a Pacific War With China It Doesn’t Want

Embedded with U.S. forces in the Pacific, I saw the dilemmas of deterrence firsthand.

Chinese Foreign Minister Wang Yi, seen in a suit and tie and in profile, walks outside the venue at the Belt and Road Forum for International Cooperation. Behind him is a sculptural tree in a larger planter that appears to be leaning away from him.
Chinese Foreign Minister Wang Yi, seen in a suit and tie and in profile, walks outside the venue at the Belt and Road Forum for International Cooperation. Behind him is a sculptural tree in a larger planter that appears to be leaning away from him.

The Endless Frustration of Chinese Diplomacy

Beijing’s representatives are always scared they could be the next to vanish.

Turkey's President Recep Tayyip Erdogan welcomes Crown Prince of Saudi Arabia Mohammed bin Salman during an official ceremony at the Presidential Complex in Ankara, on June 22, 2022.
Turkey's President Recep Tayyip Erdogan welcomes Crown Prince of Saudi Arabia Mohammed bin Salman during an official ceremony at the Presidential Complex in Ankara, on June 22, 2022.

The End of America’s Middle East

The region’s four major countries have all forfeited Washington’s trust.